Market Research Logo

Global organ transplant immunosuppressant market 2017-2021

Global organ transplant immunosuppressant market 2017-2021

About Organ Transplant Immunosuppressant

An organ transplantation is a surgical procedure that involves replacing diseased organs such as a heart, liver, kidney, or lung with healthy organs. The donor organ can come from a deceased donor (who has recently passed away) such as in heart transplants, or kidney, liver, and rarely lung transplants from living donors. As per the Centers for Disease Control and Prevention (CDC) report, the most commonly transplanted organs in the US are the kidney, liver, heart, lungs, pancreas, and intestine. On any given day, there are about 75,000 people on active waiting list for organ transplantation. However, the organ donors are very few, leading to the high unmet need for organ availability. There are only 8,000 deceased organ donors annually, with each providing on average 3.5 organs. Living donors provide on average only around 6,000 organs per year.

Technavio’s analysts forecast the global organ transplant immunosuppressant market to grow at a CAGR of 3.81% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global organ transplant immunosuppressant market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Organ Transplant Immunosuppressant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Novartis,
  • Astellas Pharma,
  • Pfizer,
  • Sanofi,
Other prominent vendors
  • AbbVie
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
Market driver
  • Increased incidence of organ failure
  • For a full, detailed list, view our report
Market challenge
  • Insufficient organ supply
  • For a full, detailed list, view our report
Market trend
  • Growing trend of medical tourism
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Organ Transplant Immunosuppressant Market 2017-2021

Technavio recognizes the following companies as the key players in the global organ transplant immunosuppressant market: Novartis, Astellas Pharma, Pfizer, and Sanofi,

Other Prominent Vendors in the market are: AbbVie, Bristol-Myers Squibb, and F. Hoffmann-La Roche.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is growing trend of medical tourism. Medical tourism is the act of traveling abroad to receive medical, dental, and cosmetic care. Medical tourism for getting an organ transplant is also called as transplant tourism, and the significantly lower cost for availing the best practice care is generally the primary motivation. In addition, the insufficient organ supply is another reason for the emergence of medical/transplant tourism. However, to bridge the gap between demand and supply, the introduction of the artificial organ has served the purpose. However, the high cost associated with artificial organ transplant, especially in the US has further compelled the individuals to visit the less developed countries to get an organ transplant at competitive prices.”

According to the report, one of the major drivers for this market is increased incidence of organ failure. Globally, there is a high demand for tissues and organs such as bone marrow, heart, liver, kidney, and lungs. The increased alcohol consumption, unhealthy lifestyles and food habits, and drug intake are the leading causes of organ failure. In addition, the rise in aging population results in increased demand for organs for transplantation.

Further, the report states that one of the major factors hindering the growth of this market is Insufficient organ supply. The global organ transplant immunosuppressant market is witnessing a high demand for donor organ due to increasing incidences of organ failure. Despite advances in the medicine and technology, and increased awareness of organ donation and transplantation, the increasing gap between supply and demand continues to pose a major challenge for the market growth.

Companies Mentioned

Novartis, Astellas Pharma, Pfizer, Sanofi,AbbVie, Bristol-Myers Squibb, and F. Hoffmann-La Roche.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
      • Table Market share of global organ transplant immunosuppressant market in the global immunology market 2016
      • Table Factors driving the global organ transplant immunosuppressant market 2016
      • Table Types of immunosuppressant
  • Introduction to organ transplantation
    • What is an organ transplantation?
    • How common is organ transplantation?
      • Table Prevalence rate of kidney and liver diseases in US adults over 18 years of age 2015
    • Increasing trend of organ transplantation
      • Table Increasing trend of transplantation in US 2003-2015
    • Need for immunosuppression during organ transplant
    • What is an immunosuppressant?
    • Role of an immunosuppressant during organ transplant
  • Market landscape
    • Market overview
      • Table Kidney and liver transplant market scenario: Deceased donors versus living donors 2014
    • Market size and forecast
      • Table Global organ transplant immunosuppressant market 2016-2021 ($ millions)
      • Table Opportunity analysis in global organ transplant immunosuppressant market
    • Five forces analysis
      • Table Five forces analysis
  • Key clinical trials
    • Table Pipeline landscape based on mechanism of action (MoA)
    • Table Key clinical trials
    • Table Key clinical studies
    • Table Clinical studies for kidney transplant
  • Market segmentation by drug class
    • Table Segmentation of global organ transplant immunosuppressant market by drug class 2016
    • Table Global organ transplant immunosuppressant market share by drug class 2016
    • Selective inhibitor of cytokine production and function
      • Table Examples of selective inhibitors of cytokine production and function
      • Table Global organ transplant immunosuppressive selective inhibitor of cytokine production and function market 2016-2021 ($ millions)
    • Immunosuppressive antimetabolites
      • Table Examples of immunosuppressive antimetabolites
      • Table Global organ transplant immunosuppressive antimetabolites market 2016-2021 ($ millions)
    • Immunosuppressive antibodies
      • Table Examples of immunosuppressive antibodies
      • Table Global organ transplant immunosuppressive antibodies market revenue 2016-2021 ($ millions)
    • Immunosuppressive adrenocorticosteroids
      • Table Examples of immunosuppressive adrenocorticosteroids
      • Table Global organ transplant immunosuppressive adrenocorticosteroids market revenue 2016-2021 ($ millions)
  • Market segmentation by therapeutic application
    • Table Segmentation of global organ transplant immunosuppressant market by therapeutic application 2016
    • Kidney transplantation
    • Liver transplantation
    • Heart transplantation
    • Lung transplantation
    • Pancreas transplantation
    • Other transplantation
  • Geographical segmentation
    • Table Segmentation of global organ transplant immunosuppressant market by geography 2016 and 2021
    • Table Global organ transplant immunosuppressant market revenue by geography 2016-2021 ($ millions)
    • Table Global organ transplant immunosuppressant market share by geography 2016 (%)
    • Organ transplant immunosuppressant market in Americas
      • Table Market scenario in Americas
      • Table Organ transplant immunosuppressant market in Americas 2016-2021 ($ millions)
    • Organ transplant immunosuppressant market in EMEA
      • Table Market scenario in EMEA
      • Table Organ transplant immunosuppressant market in EMEA 20016-2021 ($ millions)
    • Organ transplant immunosuppressant market in APAC
      • Table Market scenario in APAC
      • Table Organ transplant immunosuppressant market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Types of transplant rejection
      • Table Classification of some of the marketed immunosuppressive drugs based on their MoA
    • Market challenges
      • Table Organ transplantation scenario in US 2003-2015
      • Table Donation trend over the years:2000-2010
      • Table Legal and ethical issues in some countries
  • Market trends
    • Growing trend of medical tourism
    • New government initiatives on transplant research programs
      • Table Contribution by governments and its market impact
    • Growing focus toward the use of biologics
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global organ transplant immunosuppressant market 2016
  • Key vendor analysis
    • Astellas Pharma
      • Table Astellas Pharma: Key highlights
      • Table Astellas Pharma: Strength assessment
      • Table Astellas Pharma: Strategy assessment
      • Table Astellas Pharma: Opportunity assessment
    • Novartis
      • Table Novartis: Key highlights
      • Table Novartis: Strength assessment
      • Table Novartis: Strategy assessment
      • Table Novartis: Opportunity assessment
    • Pfizer
      • Table Pfizer: Key highlights
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Sanofi
      • Table Sanofi: Key highlights
      • Table Sanofi: Strength assessment
      • Table Sanofi: Strategy assessment
      • Table Sanofi: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report